New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
10:36 EDTAZN, URBN, BPL, FST, TJXHigh option volume stocks: TJX BPL AZN FST URBN
News For TJX;BPL;AZN;FST;URBN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 19, 2015
07:23 EDTURBNUrban Outfitters shares should be bought on weakness, says SunTrust
Subscribe for More Information
05:56 EDTURBNUrban Outfitters downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Urban Outfitters to Neutral and lowered its price target for shares to $36 from $50 after the company's Q1 results missed expectations. The firm sees pressure in Q2 and believes the retailer will be a "show me" story in the second half of 2015. Shares of Urban Outfitters were also downgraded this morning at Oppenheimer and Piper Jaffray.
05:53 EDTURBNUrban Outfitters downgraded to Perform from Outperform at Oppenheimer
Oppenheimer downgraded Urban Outfitters to Perform with a $35 price target after the company's Q1 results missed expectations. Opco says retailers typically report multiple quarters of weaker than expected results. Shares of Urban Outfitters were also downgraded this morning at Piper Jaffray.
05:50 EDTURBNUrban Outfitters downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Urban Outfitters to Neutral with a $36 price target citing near-term transition uncertainty after the retailer's Q1 results missed expectations.
May 18, 2015
20:16 EDTURBNUrban Outfitters down over 16% after disappointing Q1 results
Urban Oufitters (URBN) is down sharply after reporting first quarter earnings per share and revenue that missed analyst estimates. WHAT'S NEW: Urban Oufitters reported Q1 EPS of 25c on revenue of $739.01M, below consensus expectations of 30c and $758.25M, respectively. Urban Outfitters also reported Q1 comparable retail segment net sales up 4%, with Q1 retail segment net sales increasing 17% at Free People, 5% at Urban Outfitters, and 1% at the Anthropologie Group. Wholesale segment net sales rose 18%. WHAT'S NOTABLE: On its Q1 earnings conference call, Urban Outfitters announced that Urban Outfitters Group CEO Ted Marlow, who oversaw the direction of the namesake brand, would retire at the end of August. While Urban Outfitters did not provide guidance, Urban Outfitters Anthropologie Group CEO David McCreight commented on the Anthropologie brand, "We're expecting we could see Q2 shaping up like Q1 in terms of low single-digit comps. We could also see being in the low-mid-single digit comps. It's hard to tell at this point." ANALYST REACTION: Two analyst firms lowered their respective price targets on Urban Outfitters following the company's earnings report. Sterne Agee, which rates Urban Outfitters a Neutral, lowered its 12-month price target to $34 from $46, noting the company has had trouble getting both its Urban Outfitters and Anthropologie brands to perform at the same time. Cantor, which maintained its Buy rating, lowered its price target to $53 from $54, saying that Anthropologie sales disappointed, but noting that a "later catalog release appears to us to have pushed some sales at Anthropologie into May." PRICE ACTION: Urban Outfitters fell 16.4% to just over $34 in after-hours trading. PEERS: Other publicly traded companies in the space include Abercrombie & Fitch (ANF), American Eagle (AEO), Five Below (FIVE), Pacific Sunwear (PSUN), and Zumiez (ZUMZ).
19:12 EDTURBNOn The Fly: After Hours Movers
Subscribe for More Information
16:40 EDTURBNUrban Outfitters down 13% following weaker than expected Q1 results
Subscribe for More Information
16:03 EDTURBNUrban Outfitters reports Q1 comparable retail segment net sales up 4%
Comparable Q1 retail segment net sales increased 17% at Free People, 5% at Urban Outfitters and 1% at the Anthropologie Group. Wholesale segment net sales rose 18%.
16:02 EDTURBNUrban Outfitters reports Q1 EPS 25c, consensus 30c
Reports Q1 revenue $739.01M, consensus $758.25M.
15:39 EDTTJXTJX technical notes before results
There is a small potential bullish, inverted, head and shoulders pattern on the daily chart. The neckline for the pattern, the trigger point for the pattern to be considered active, is at $67.50 which is just above the 50-day moving average. Upside potential for the pattern if it triggered and completed would be to the $71.50 to $72 area which would mark fresh 52-week highs. If the news is bearish, the first significant support level to watch would be the pivot low at $63.66. That pivot is the highest point in the head of the bullish head and shoulders pattern noted above. Support below this pivot would be at $61.50.
15:29 EDTURBNOptions with increasing volume
Options with increasing volume: ACHN PAGP CBG NI NGLS LEA OKS GTI WETF URBN
15:18 EDTTJXTJX June volatility increases into Q1 and outlook
TJX June call option implied volatility is at 23, July and October is at 20; compared to its 90-day average of 20, suggesting larger near term price movement into the expected release of Q1 on May 19.
15:14 EDTURBNUrban Outfitters technical comments ahead of earnings
Subscribe for More Information
15:00 EDTTJXNotable companies reporting before tomorrow's open
Subscribe for More Information
15:00 EDTURBNNotable companies reporting after market close
Subscribe for More Information
12:04 EDTTJXTJX management to meet with Guggenheim
Meeting to be held in Framingham, MA on May 20 hosted by Guggenheim.
10:10 EDTURBNHigh option volume stocks
07:31 EDTURBNUrban Outfitters brands positioned for market share gains, says Brean Capital
Subscribe for More Information
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use